Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Repetin is a structural protein expressed in the human epidermis, encoded by the RPTN gene. It is a member of the S100 fused-type protein family and contains an EF-hand calcium-binding domain. Repetin is localized in the epidermal differentiation complex and is involved in the formation of the cornified cell envelope—a critical component of skin barrier function. It is reversibly calcium-binding and a key extracellular matrix protein that contributes to the mechanical stability and structural integrity of terminally differentiated keratinocytes. Disease associations are limited to genetic skin disorders involving abnormal keratinization, such as ichthyosis vulgaris and autosomal recessive congenital ichthyosis. Repetin is neither a classical receptor nor a typical drug target, but its function is crucial for epidermal differentiation and protection.
Not applicable. No drugs or therapeutic agents are known to act directly on repetin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Repetin (RPTN).